By Josh White
Date: Thursday 11 Sep 2025
(Sharecast News) - Aptamer Group said Thursday that it has signed a new contract with Metir to develop synthetic Optimer binders for rapid cryptosporidium detection in Metir's next-generation water pathogen monitoring platform.
Share Incentive Plan - Director/PDMR Shareholding | 12-Sep-2025 | 16:00 | RNS |
Grant of Options | 12-Sep-2025 | 07:00 | RNS |
Transaction in Own Shares | 12-Sep-2025 | 07:00 | RNS |
Transaction in Own Shares | 12-Sep-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 11-Sep-2025 | 12:20 | RNS |
Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
Investment Column:BTG | 06-Oct-2011 | The Independent |
Investment Column:Genus | 09-Sep-2011 | The Independent |
Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
Price | 22,121.28 |
Closing Price Change | -267.20 |
% Change | -1.19 % |
12-Sep-25 Close | 22,121.28 |
You are here: research